Registration, Evaluation, Authorisation and Restriction of Chemicals
EU chemicals framework protecting health and environment.
Sectors
ChemicalsImport / WholesaleManufacturingAutomotiveElectronicsEnvironmental ServicesHealthcare & Pharma
Articles (141)
Article 82 — Voting of the Management BoardArticle 83 — Duties and powers of the Executive DirectorArticle 84 — Appointment of the Executive DirectorArticle 85 — Establishment of the CommitteesArticle 86 — Establishment of the ForumArticle 87 — Rapporteurs of Committees and use of expertsArticle 88 — Qualification and interestsArticle 89 — Establishment of the Board of AppealArticle 90 — Members of the Board of AppealArticle 91 — Decisions subject to appealArticle 92 — Persons entitled to appeal, time-limits, fees and formArticle 93 — Examination and decisions on appealArticle 94 — Actions before the Court of First Instance and the Court of JusticeArticle 95 — Conflicts of opinion with other bodiesArticle 96 — The budget of the AgencyArticle 97 — Implementation of the budget of the AgencyArticle 98 — Combating fraudArticle 99 — Financial rulesArticle 100 — Legal personality of the AgencyArticle 101 — Liability of the AgencyArticle 102 — Privileges and immunities of the AgencyArticle 103 — Staff rules and regulationsArticle 104 — LanguagesArticle 105 — Duty of confidentialityArticle 106 — Participation of third countriesArticle 107 — Participation of international organisationsArticle 108 — Contacts with stakeholder organisationsArticle 109 — Rules on transparencyArticle 110 — Relations with relevant Community bodiesArticle 111 — Formats and software for submission of information to the AgencyArticle 112 — ScopeArticle 113 — Obligation to notify the AgencyArticle 114 — Classification and labelling inventoryArticle 115 — Harmonisation of classification and labellingArticle 116 — Transitional arrangementsArticle 117 — ReportingArticle 118 — Access to informationArticle 119 — Electronic public accessArticle 120 — Cooperation with third countries and international organisationsArticle 121 — AppointmentArticle 122 — Cooperation between competent authoritiesArticle 123 — Communication to the public of information on risks of substancesArticle 124 — Other responsibilitiesArticle 125 — Tasks of the Member StatesArticle 126 — Penalties for non-complianceArticle 127 — ReportArticle 128 — Free movementArticle 129 — Safeguard clauseArticle 130 — Statement of reasons for decisionsArticle 131 — Amendments to the AnnexesArticle 132 — Implementing legislationArticle 133 — Committee procedureArticle 134 — Preparation of establishment of the AgencyArticle 135 — Transitional measures regarding notified substancesArticle 136 — Transitional measures regarding existing substancesArticle 137 — Transitional measures regarding restrictionsArticle 138 — ReviewArticle 139 — RepealsArticle 140 — Amendment of Directive 1999/45/ECArticle 141 — Entry into force and applicationArticle 1 — Aim and scopeArticle 2 — ApplicationArticle 3 — DefinitionsArticle 4 — General provisionArticle 5 — No data, no marketArticle 6 — General obligation to register substances on their own or in preparationsArticle 7 — Registration and notification of substances in articlesArticle 8 — Only representative of a non-Community manufacturerArticle 9 — Exemption from the general obligation to register for product and process orientated research and development (PPORD)Article 10 — Information to be submitted for general registration purposesArticle 11 — Joint submission of data by multiple registrantsArticle 12 — Information to be submitted depending on tonnageArticle 13 — General requirements for generation of information on intrinsic properties of substancesArticle 14 — Chemical safety report and duty to apply and recommend risk reduction measuresArticle 15 — Substances in plant protection and biocidal productsArticle 16 — Duties of the Commission, the Agency and registrants of substances regarded as being registeredArticle 17 — Registration of on-site isolated intermediatesArticle 18 — Registration of transported isolated intermediatesArticle 19 — Joint submission of data on isolated intermediates by multiple registrantsArticle 20 — Duties of the AgencyArticle 21 — Manufacturing and import of substancesArticle 22 — Further duties of registrantsArticle 23 — Specific provisions for phase-in substancesArticle 24 — Notified substancesArticle 25 — Objectives and general rulesArticle 26 — Duty to inquire prior to registrationArticle 27 — Sharing of existing data in the case of registered substancesArticle 28 — Duty to pre-register for phase-in substancesArticle 29 — Substance Information Exchange ForumsArticle 30 — Sharing of data involving testsArticle 31 — Requirements for safety data sheetsArticle 32 — Duty to communicate information down the supply chain for substances on their own or in preparations for which a safety data sheet is not requiredArticle 33 — Duty to communicate information on substances in articlesArticle 34 — Duty to communicate information on substances and preparations up the supply chainArticle 35 — Access to information for workersArticle 36 — Obligation to keep informationArticle 37 — Downstream user chemical safety assessments and duty to identify, apply and recommend risk reduction measuresArticle 38 — Obligation for downstream users to report informationArticle 39 — Application of downstream user obligationsArticle 40 — Examination of testing proposalsArticle 41 — Compliance check of registrationsArticle 42 — Check of information submitted and follow-up to dossier evaluationArticle 43 — Procedure and time periods for examination of testing proposalsArticle 44 — Criteria for substance evaluationArticle 45 — Competent authorityArticle 46 — Requests for further information and check of information submittedArticle 47 — Coherence with other activitiesArticle 48 — Follow-up to substance evaluationArticle 49 — Further information on on-site isolated intermediatesArticle 50 — Registrants' and downstream users' rightsArticle 51 — Adoption of decisions under dossier evaluationArticle 52 — Adoption of decisions under substance evaluationArticle 53 — Cost sharing for tests without an agreement between registrants and/or downstream usersArticle 54 — Publication of information on evaluationArticle 55 — Aim of authorisation and considerations for substitutionArticle 56 — General provisionsArticle 57 — Substances to be included in Annex XIVArticle 58 — Inclusion of substances in Annex XIVArticle 59 — Identification of substances referred to in Article 57Article 60 — Granting of authorisationsArticle 61 — Review of authorisationsArticle 62 — Applications for authorisationsArticle 63 — Subsequent applications for authorisationArticle 64 — Procedure for authorisation decisionsArticle 65 — Obligation of holders of authorisationsArticle 66 — Downstream usersArticle 67 — General provisionsArticle 68 — Introducing new and amending current restrictionsArticle 69 — Preparation of a proposalArticle 70 — Agency opinion: Committee for Risk AssessmentArticle 71 — Agency opinion: Committee for Socio-economic AnalysisArticle 72 — Submission of an opinion to the CommissionArticle 73 — Commission decisionArticle 74 — Fees and chargesArticle 75 — Establishment and reviewArticle 76 — CompositionArticle 77 — TasksArticle 78 — Powers of the Management BoardArticle 79 — Composition of the Management BoardArticle 80 — Chairmanship of the Management BoardArticle 81 — Meetings of the Management Board